Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could an Iron-Removing drug slow ALS? new trial results are in

NCT ID NCT03293069

First seen Dec 08, 2025 · Last updated May 23, 2026 · Updated 25 times

Summary

This study tested whether a drug called deferiprone, which removes extra iron from the brain, could slow the progression of ALS (Lou Gehrig's disease). The trial included 372 adults with early-stage ALS. Researchers measured changes in physical function and survival over 12 months to see if the drug helped.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Aphm Hopital La Timone

    Marseille, France

  • C H U Dupuytren Limoges

    Limoges, France

  • Chr Angers

    Angers, France

  • Chru Brest

    Brest, France

  • Chu Cote de Nacre - Caen

    Caen, France

  • Chu Toulouse

    Toulouse, 31300, France

  • Chu de Bordeaux - Talence

    Talence, France

  • Chu de Clermont-Ferrand

    Clermont-Ferrand, France

  • Chu de Nancy

    Nancy, France

  • Chu de Nice Hopital Pasteur

    Nice, France

  • Chu de Tours

    Tours, France

  • Hopital Pierre Wertheimer - Hcl - Bron

    Bron, France

  • Hopital de Hautepierre

    Strasbourg, 67091, France

  • Hu Pitie Salpetriere Aphp

    Paris, 75013, France

  • Hôpital Roger Salengro, CHU

    Lille, 59000, France

Conditions

Explore the condition pages connected to this study.